Abstract
For many years, several studies have explored the molecular mechanisms involved in the infection of bacteria by their specific phages to understand the main infection strategies and the host defense strategies. The modulation of the mechanisms involved in the infection, as well as the expression of key substances in the development of the different life cycles of phages, function as a natural source of strategies capable of promoting the control of different pathogens that are harmful to human and animal health. Therefore, this chapter aims to provide an overview of the mechanisms involved in virus-bacteria interaction to explore the main compounds produced or altered as a chemical survival strategy and the metabolism modulation when occurring a host-phage interaction. In this context, emphasis will be given to the chemistry of peptides/proteins and enzymes encoded by bacteriophages in the control of pathogenic bacteria and the use of secondary metabolites recently reported as active participants in the mechanisms of phage-bacteria interaction. Finally, metabolomics strategies developed to gain new insights into the metabolism involved in the phage-host interaction and the metabolomics workflow in host-phage interaction will be presented.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mohr KI (2016) History of antibiotics research. In: Current topics in microbiology and immunology. Springer, pp 237ā272
Collignon P, McEwen S (2019) One health ā its importance in helping to better control antimicrobial resistance. Trop Med Infect Dis 4:22. https://doi.org/10.3390/tropicalmed4010022
Klein EY, Van Boeckel TP, Martinez EM et al (2018) Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proc Natl Acad Sci U S A 115:E3463āE3470. https://doi.org/10.1073/pnas.1717295115
Davies J (2006) Where have all the antibiotics gone? In: Canadian Journal of Infectious Diseases and Medical Microbiology. Hindawi Limited, pp 287ā290
World Health Organization (1983) Antimicrobial resistance. Bull World Health Organ 61:383ā394
Asadi A, Razavi S, Talebi M, Gholami M (2019) A review on anti-adhesion therapies of bacterial diseases. Infection 47:13ā23. https://doi.org/10.1007/s15010-018-1222-5
Peterson E, Kaur P (2018) Antibiotic resistance mechanisms in bacteria: relationships between resistance determinants of antibiotic producers, environmental bacteria, and clinical pathogens. Front Microbiol 9:2928. https://doi.org/10.3389/fmicb.2018.02928
Davies J, Davies D (2010) Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev 74:417ā433. https://doi.org/10.1128/MMBR.00016-10
Reygaert WC (2018) An overview of the antimicrobial resistance mechanisms of bacteria. AIMS Microbiol 4:482ā501. https://doi.org/10.3934/microbiol.2018.3.482
Tacconelli E, Carrara E, Savoldi A et al (2018) Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis 18:318ā327. https://doi.org/10.1016/S1473-3099(17)30753-3
Antibiotic / Antimicrobial resistance | CDC. https://www.cdc.gov/DrugResistance/. Accessed 28 Apr 2023
Shallcross LJ, Howard SJ, Fowler T, Davies SC (2015) Tackling the threat of antimicrobial resistance: from policy to sustainable action. Philos Trans R Soc B Biol Sci 370:20140082. https://doi.org/10.1098/rstb.2014.0082
Iskandar K, Murugaiyan J, Hammoudi Halat D et al (2022) Antibiotic discovery and resistance: the chase and the race. Antibiotics 11:182. https://doi.org/10.3390/antibiotics11020182
Wittebole X, De Roock S, Opal SM (2014) A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens. Virulence 5:226ā235. https://doi.org/10.4161/viru.25991
Rolain J-M, Hraiech S, Bregeon F (2015) Bacteriophage-based therapy in cystic fibrosis-associated Pseudomonas aeruginosa infections: rationale and current status. Drug Des Devel Ther 9:3653. https://doi.org/10.2147/DDDT.S53123
Dy RL, Rigano LA, Fineran PC (2018) Phage-based biocontrol strategies and their application in agriculture and aquaculture. Biochem Soc Trans 46:1605ā1613. https://doi.org/10.1042/BST20180178
Vu NT, Oh C-S (2020) Bacteriophage usage for bacterial disease management and diagnosis in plants. Plant Pathol J 36:204ā217. https://doi.org/10.5423/PPJ.RW.04.2020.0074
Dewanggana MN, Evangeline C, Ketty MD et al (2022) Isolation, characterization, molecular analysis and application of bacteriophage DW-EC to control Enterotoxigenic Escherichia coli on various foods. Sci Rep 12:495. https://doi.org/10.1038/s41598-021-04534-8
Kawacka I, Olejnik-Schmidt A, Schmidt M, Sip A (2020) Effectiveness of phage-based inhibition of listeria monocytogenes in food products and food processing environments. Microorganisms 8:1764. https://doi.org/10.3390/microorganisms8111764
Huang Z, Zhang Z, Tong J et al (2021) Phages and their lysins: toolkits in the battle against foodborne pathogens in the postantibiotic era. Compr Rev Food Sci Food Saf 20:3319ā3343. https://doi.org/10.1111/1541-4337.12757
Smith HW, Huggins MB (1982) Successful treatment of experimental Escherichia coli infections in mice using phage: its general superiority over antibiotics. Microbiology 128:307ā318. https://doi.org/10.1099/00221287-128-2-307
Williams Smith H, Huggins MB (1983) Effectiveness of phages in treating experimental Escherichia coli diarhoea in calves, piglets and lambs. J Gen Microbiol 129:2659ā2675. https://doi.org/10.1099/00221287-129-8-2659
Melo LDR, Oliveira H, Pires DP et al (2020) Phage therapy efficacy: a review of the last 10 years of preclinical studies. Crit Rev Microbiol 46:78ā99. https://doi.org/10.1080/1040841X.2020.1729695
Slopek S, Weber-Dabrowska B, Dabrowski M, Kucharewicz-Krukowska A (1987) Results of bacteriophage treatment of suppurative bacterial infections in the years 1981-1986. Arch Immunol Ther Exp 35:569ā583
Cislo M, Dabrowski M, Weber-Dabrowska B, Woyton A (1987) Bacteriophage treatment of suppurative skin infections. Arch Immunol Ther Exp 35:175ā183
Wright A, Hawkins CH, ĆnggĆ„rd EE, Harper DR (2009) A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy. Clin Otolaryngol 34:349ā357. https://doi.org/10.1111/j.1749-4486.2009.01973.x
Fukuda K, Ishida W, Uchiyama J et al (2012) Pseudomonas aeruginosa keratitis in mice: effects of topical bacteriophage KPP12 administration. PLoS One 7. https://doi.org/10.1371/JOURNAL.PONE.0047742
Basu S, Agarwal M, Kumar Bhartiya S et al (2015) An in vivo wound model utilizing bacteriophage therapy of Pseudomonas aeruginosa biofilms. Ostomy Wound Manage 61:16ā23
Maddocks S, Fabijan AP, Ho J et al (2019) Bacteriophage therapy of ventilator-associated pneumonia and empyema caused by Pseudomonas aeruginosa. Am J Respir Crit Care Med 200:1179ā1181. https://doi.org/10.1164/rccm.201904-0839LE
Soothill JS (1992) Treatment of experimental infections of mice with bacteriophages. J Med Microbiol 37:258ā261. https://doi.org/10.1099/00222615-37-4-258
Schooley RT, Biswas B, Gill JJ et al (2017) Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection. Antimicrob Agents Chemother 61. https://doi.org/10.1128/AAC.00954-17
Knirel YA, Shneider MM, Popova AV et al (2020) Mechanisms of Acinetobacter baumannii capsular polysaccharide cleavage by phage depolymerases. Biochemist 85:567ā574. https://doi.org/10.1134/S0006297920050053
Volozhantsev NV, Shpirt AM, Borzilov AI et al (2020) Characterization and therapeutic potential of bacteriophage-encoded polysaccharide depolymerases with Ī² galactosidase activity against Klebsiella pneumoniae K57 capsular type. Antibiotics 9:732. https://doi.org/10.3390/antibiotics9110732
Tanji Y, Shimada T, Fukudomi H et al (2005) Therapeutic use of phage cocktail for controlling Escherichia coli O157:H7 in gastrointestinal tract of mice. J Biosci Bioeng 100:280ā287. https://doi.org/10.1263/jbb.100.280
Bryan D, El-Shibiny A, Hobbs Z et al (2016) Bacteriophage T4 infection of stationary phase E. coli: life after log from a phage perspective. Front Microbiol 7. https://doi.org/10.3389/fmicb.2016.01391
Lehman SM, Mearns G, Rankin D et al (2019) Design and preclinical development of a phage product for the treatment of antibiotic-resistant staphylococcus aureus infections. Viruses 88(11):88. https://doi.org/10.3390/V11010088
Petrovic Fabijan A, Lin RCY, Ho J et al (2020) Safety of bacteriophage therapy in severe Staphylococcus aureus infection. Nat Microbiol 5:465ā472. https://doi.org/10.1038/s41564-019-0634-z
Weinbauer MG (2004) Ecology of prokaryotic viruses. FEMS Microbiol Rev 28:127ā181. https://doi.org/10.1016/j.femsre.2003.08.001
Labrie SJ, Samson JE, Moineau S (2010) Bacteriophage resistance mechanisms. Nat Rev Microbiol 8:317ā327. https://doi.org/10.1038/nrmicro2315
Hendrix H, Zimmermann-Kogadeeva M, Zimmermann M et al (2022) Metabolic reprogramming of Pseudomonas aeruginosa by phage-based quorum sensing modulation. Cell Rep 38:110372. https://doi.org/10.1016/j.celrep.2022.110372
De Smet J, Zimmermann M, Kogadeeva M et al (2016) High coverage metabolomics analysis reveals phage-specific alterations to Pseudomonas aeruginosa physiology during infection. ISME J 10:1823ā1835. https://doi.org/10.1038/ismej.2016.3
Kutter E, Bryan D, Ray G et al (2018) From host to phage metabolism: hot tales of phage T4ās takeover of E. coli. Viruses 10:387. https://doi.org/10.3390/v10070387
Pini A, Giuliani A, Falciani C et al (2005) Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification. Antimicrob Agents Chemother 49:2665ā2672. https://doi.org/10.1128/AAC.49.7.2665-2672.2005
Bishop-Hurley SL, Rea PJ, McSweeney CS (2010) Phage-displayed peptides selected for binding to Campylobacter jejuni are antimicrobial. Protein Eng Des Sel 23:751ā757. https://doi.org/10.1093/protein/gzq050
Larpin Y, Oechslin F, Moreillon P et al (2018) In vitro characterization of PlyE146, a novel phage lysin that targets Gram-negative bacteria. PLoS One 13:e0192507. https://doi.org/10.1371/journal.pone.0192507
Bin Hafeez A, Jiang X, Bergen PJ, Zhu Y (2021) Antimicrobial peptides: an update on classifications and databases. Int J Mol Sci 22:11691. https://doi.org/10.3390/ijms222111691
Al-Wrafy F, Brzozowska E, GĆ³rska S et al (2019) Identification and characterization of phage protein and its activity against two strains of multidrug-resistant Pseudomonas aeruginosa. Sci Rep 9:13487. https://doi.org/10.1038/s41598-019-50030-5
De Smet J, Wagemans J, Boon M et al (2021) The bacteriophage LUZ24 āIgyā peptide inhibits the Pseudomonas DNA gyrase. Cell Rep 36:109567. https://doi.org/10.1016/j.celrep.2021.109567
Kever L, HĆ¼nnefeld M, Brehm J et al (2021) Identification of Gip as a novel phage-encoded gyrase inhibitor protein of Corynebacterium glutamicum. Mol Microbiol 116:1268ā1280. https://doi.org/10.1111/mmi.14813
Glonti T, Chanishvili N, Taylor PW (2010) Bacteriophage-derived enzyme that depolymerizes the alginic acid capsule associated with cystic fibrosis isolates of Pseudomonas aeruginosa. J Appl Microbiol 108:695ā702. https://doi.org/10.1111/j.1365-2672.2009.04469.x
Drulis-Kawa Z, Majkowska-Skrobek G, Maciejewska B et al (2012) Learning from bacteriophages ā advantages and limitations of phage and phage-encoded protein applications. Curr Protein Pept Sci 13:699. https://doi.org/10.2174/138920312804871193
Sainath Rao S, Mohan KVK, Atreya CD (2013) A peptide derived from phage display library exhibits antibacterial activity against E. coli and Pseudomonas aeruginosa. PLoS One 8:e56081. https://doi.org/10.1371/journal.pone.0056081
Briers Y, Walmagh M, Grymonprez B et al (2014) Art-175 is a highly efficient antibacterial against multidrug-resistant strains and persisters of Pseudomonas aeruginosa. Antimicrob Agents Chemother 58:3774ā3784. https://doi.org/10.1128/AAC.02668-14/SUPPL_FILE/ZAC007143000SO1.PDF
Pires DP, Oliveira H, Melo LDR et al (2016) Bacteriophage-encoded depolymerases: their diversity and biotechnological applications. Appl Microbiol Biotechnol 100:2141ā2151. https://doi.org/10.1007/s00253-015-7247-0
Thandar M, Lood R, Winer BY et al (2016) Novel engineered peptides of a phage lysin as effective antimicrobials against multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 60:2971ā2979. https://doi.org/10.1128/AAC.02972-15
Peng SY, You RI, Lai MJ et al (2017) Highly potent antimicrobial modified peptides derived from the Acinetobacter baumannii phage endolysin LysAB2. Sci Rep 7:1ā12. https://doi.org/10.1038/s41598-017-11832-7
Latka A, Maciejewska B, Majkowska-Skrobek G et al (2017) Bacteriophage-encoded virion-associated enzymes to overcome the carbohydrate barriers during the infection process. Appl Microbiol Biotechnol 101:3103ā3119. https://doi.org/10.1007/s00253-017-8224-6
Forterre P (2010) Defining life: the virus viewpoint. Orig Life Evol Biosph 40:151ā160. https://doi.org/10.1007/s11084-010-9194-1
Forterre P (2016) To be or not to be alive: how recent discoveries challenge the traditional definitions of viruses and life. Stud Hist Philos Sci Part C Stud Hist Philos Biol Biomed Sci 59:100ā108. https://doi.org/10.1016/j.shpsc.2016.02.013
Nasir A, Romero-Severson E, Claverie J-M (2020) Investigating the concept and origin of viruses. Trends Microbiol 28:959ā967. https://doi.org/10.1016/j.tim.2020.08.003
Moniruzzaman M, Martinez-Gutierrez CA, Weinheimer AR, Aylward FO (2020) Dynamic genome evolution and complex virocell metabolism of globally-distributed giant viruses. Nat Commun 11:1710. https://doi.org/10.1038/s41467-020-15507-2
Woese CR, Fox GE (1977) Phylogenetic structure of the prokaryotic domain: the primary kingdoms. Proc Natl Acad Sci 74:5088ā5090. https://doi.org/10.1073/pnas.74.11.5088
Farner DS (1983) The growth of biological thought. Diversity, evolution, and inheritance. Auk 100:507ā549. https://doi.org/10.1093/auk/100.2.507
Woese CR (1987) Bacterial evolution. Microbiol Rev 51:221ā271. https://doi.org/10.1128/MR.51.2.221-271.1987
Woese CR, Kandler O, Wheelis ML (1990) Towards a natural system of organisms: proposal for the domains Archaea, Bacteria, and Eucarya. Proc Natl Acad Sci 87:4576ā4579. https://doi.org/10.1073/pnas.87.12.4576
Ochman H, Moran NA (2001) Genes lost and genes found: evolution of bacterial pathogenesis and symbiosis. Science (80- ) 292:1096ā1099. https://doi.org/10.1126/science.1058543
Stanier RY, Niel CB (1962) The concept of a bacterium. Arch Mikrobiol 42:17ā35. https://doi.org/10.1007/BF00425185
Sapp J (2005) The prokaryote-eukaryote dichotomy: meanings and mythology. Microbiol Mol Biol Rev 69:292ā305. https://doi.org/10.1128/MMBR.69.2.292-305.2005
BrĆ¼ssow H, Canchaya C, Hardt W-D (2004) Phages and the evolution of bacterial pathogens: from genomic rearrangements to lysogenic conversion. Microbiol Mol Biol Rev 68:560ā602. https://doi.org/10.1128/MMBR.68.3.560-602.2004
Clokie MRJ, Millard AD, Letarov AV, Heaphy S (2011) Phages in nature. Bacteriophage 1:31ā45. https://doi.org/10.4161/bact.1.1.14942
Little JW (2014) Lysogeny, prophage induction, and lysogenic conversion. Phages 37ā54. https://doi.org/10.1128/9781555816506.CH3
Correa AMS, Howard-Varona C, Coy SR et al (2021) Revisiting the rules of life for viruses of microorganisms. Nat Rev Microbiol 19:501ā513. https://doi.org/10.1038/s41579-021-00530-x
Edlin G, Lin L, Kudrna R (1975) Ī» Lysogens of E. coli reproduce more rapidly than non-lysogens. Nature 255:735ā737. https://doi.org/10.1038/255735a0
Lin L, Bitner R, Edlin G (1977) Increased reproductive fitness of Escherichia coli lambda lysogens. J Virol 21:554ā559. https://doi.org/10.1128/jvi.21.2.554-559.1977
Waldor MK, Mekalanos JJ (1996) Lysogenic conversion by a filamentous phage encoding cholera toxin. Science (80- ) 272:1910ā1914. https://doi.org/10.1126/science.272.5270.1910
Sekulovic O, Meessen-Pinard M, Fortier L-C (2011) Prophage-stimulated toxin production in Clostridium difficile NAP1/027 lysogens. J Bacteriol 193:2726ā2734. https://doi.org/10.1128/JB.00787-10
Chan BK, Abedon ST, Loc-Carrillo C (2013) Phage cocktails and the future of phage therapy. Future Microbiol 8:769ā783. https://doi.org/10.2217/fmb.13.47
Argov T, Azulay G, Pasechnek A et al (2017) Temperate bacteriophages as regulators of host behavior. Curr Opin Microbiol 38:81ā87. https://doi.org/10.1016/j.mib.2017.05.002
Abedon ST, Duffy S, Turner PE (2009) Bacteriophage ecology. In: Encyclopedia of microbiology. Elsevier, pp 42ā57
Feiner R, Argov T, Rabinovich L et al (2015) A new perspective on lysogeny: prophages as active regulatory switches of bacteria. Nat Rev Microbiol 13:641ā650. https://doi.org/10.1038/nrmicro3527
Hatfull GF, Hendrix RW (2011) Bacteriophages and their genomes. Curr Opin Virol 1:298ā303. https://doi.org/10.1016/j.coviro.2011.06.009
Ackermann HW (2011) Bacteriophage taxonomy. Microbiol Aust 32:90. https://doi.org/10.1071/MA11090
Tolstoy I, Kropinski AM, Brister JR (2018) Bacteriophage taxonomy: an evolving discipline. In: Methods in molecular biology. Humana Press, New York, pp 57ā71
Shang J, Jiang J, Sun Y (2021) Bacteriophage classification for assembled contigs using graph convolutional network. Bioinformatics 37:I25āI33. https://doi.org/10.1093/bioinformatics/btab293
Taxonomy browser (Nematoda). https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&id=28883&lvl=3&lin=f&keep=1&srchmode=1&unlock. Accessed 1 May 2022
Krupovic M, Prangishvili D, Hendrix RW, Bamford DH (2011) Genomics of bacterial and archaeal viruses: dynamics within the prokaryotic virosphere. Microbiol Mol Biol Rev 75:610ā635. https://doi.org/10.1128/mmbr.00011-11
Buckling A, Rainey PB (2002) Antagonistic coevolution between a bacterium and a bacteriophage. Proc R Soc Lond Ser B Biol Sci 269:931ā936. https://doi.org/10.1098/rspb.2001.1945
Bertozzi Silva J, Storms Z, Sauvageau D (2016) Host receptors for bacteriophage adsorption. FEMS Microbiol Lett 363:fnw002. https://doi.org/10.1093/femsle/fnw002
Nordstrƶm K, Forsgren A (1974) Effect of protein A on adsorption of bacteriophages to Staphylococcus aureus. J Virol 14:198ā202. https://doi.org/10.1128/jvi.14.2.198-202.1974
Pedruzzi I, Rosenbusch JP, Locher KP (1998) Inactivation in vitro of the Escherichia coli outer membrane protein FhuA by a phage T5-encoded lipoprotein. FEMS Microbiol Lett 168:119ā125. https://doi.org/10.1111/J.1574-6968.1998.TB13264.X
Hammad AMM (1998) Evaluation of alginate-encapsulated Azotobacter chroococcum as a phage-resistant and an effective inoculum. J Basic Microbiol 38:9ā16. https://doi.org/10.1002/(SICI)1521-4028(199803)38:1
Cote GL, Krull LH (1988) Characterization of the exocellular polysaccharides from Azotobacter chroococcum. Carbohydr Res 181:143ā152. https://doi.org/10.1016/0008-6215(88)84030-8
Perry LL, SanMiguel P, Minocha U et al (2009) Sequence analysis of Escherichia coli O157:H7 bacteriophage ĆĀ¦V10 and identification of a phage-encoded immunity protein that modifies the O157 antigen. FEMS Microbiol Lett 292:182ā186. https://doi.org/10.1111/j.1574-6968.2009.01511.x
van Houte S, Buckling A, Westra ER (2016) Evolutionary ecology of prokaryotic immune mechanisms. Microbiol Mol Biol Rev 80:745ā763. https://doi.org/10.1128/MMBR.00011-16
Burmeister AR, Fortier A, Roush C et al (2020) Pleiotropy complicates a trade-off between phage resistance and antibiotic resistance. Proc Natl Acad Sci U S A 117:11207ā11216. https://doi.org/10.1073/pnas.1919888117
Trudelle DM, Bryan DW, Hudson LK, Denes TG (2019) Cross-resistance to phage infection in Listeria monocytogenes serotype 1/2a mutants. Food Microbiol 84:103239. https://doi.org/10.1016/j.fm.2019.06.003
Yu H, Shang L, Yang G et al (2022) Biosynthetic microcin J25 exerts strong antibacterial, anti-inflammatory activities, low cytotoxicity without increasing drug-resistance to bacteria target. Front Immunol 13:1. https://doi.org/10.3389/fimmu.2022.811378
Parker JK, Davies BW (2022) Microcins reveal natural mechanisms of bacterial manipulation to inform therapeutic development. Microbiology 168:001175. https://doi.org/10.1099/mic.0.001175
Vincent P, Morero R (2009) The structure and biological aspects of peptide antibiotic microcin J25. Curr Med Chem 16:538ā549. https://doi.org/10.2174/092986709787458461
Destoumieux-GarzĆ³n D, Duquesne S, Peduzzi J et al (2005) The iron-siderophore transporter FhuA is the receptor for the antimicrobial peptide microcin J25: role of the microcin Val11-Pro16 Ī²-hairpin region in the recognition mechanism. Biochem J 389:869ā876. https://doi.org/10.1042/BJ20042107
Mathavan I, Zirah S, Mehmood S et al (2014) Structural basis for hijacking siderophore receptors by antimicrobial lasso peptides. Nat Chem Biol 10:340ā342. https://doi.org/10.1038/NCHEMBIO.1499
Luria SE, Human ML (1952) A nonhereditary, host-induced variation of bacterial viruses. J Bacteriol 64:557ā569. https://doi.org/10.1128/jb.64.4.557-569.1952
Tock MR, Dryden DTF (2005) The biology of restriction and anti-restriction. Curr Opin Microbiol 8:466ā472. https://doi.org/10.1016/j.mib.2005.06.003
Luria SE (1953) Host-induced modifications of viruses. Cold Spring Harb Symp Quant Biol 18:237ā244. https://doi.org/10.1101/SQB.1953.018.01.034
Garneau JE, Dupuis M-Ć, Villion M et al (2010) The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature 468:67ā71. https://doi.org/10.1038/nature09523
Deveau H, Barrangou R, Garneau JE et al (2008) Phage response to CRISPR-encoded resistance in Streptococcus thermophilus. J Bacteriol 190:1390ā1400. https://doi.org/10.1128/JB.01412-07
Bondy-Denomy J, Pawluk A, Maxwell KL, Davidson AR (2013) Bacteriophage genes that inactivate the CRISPR/Cas bacterial immune system. Nature 493:429ā432. https://doi.org/10.1038/nature11723
Wiedenheft B (2013) In defense of phage. RNA Biol 10:886ā890. https://doi.org/10.4161/rna.23591
Seed KD, Lazinski DW, Calderwood SB, Camilli A (2013) A bacteriophage encodes its own CRISPR/Cas adaptive response to evade host innate immunity. Nature 494:489ā491. https://doi.org/10.1038/nature11927
Hanlon GW, Denyer SP, Olliff CJ, Ibrahim LJ (2001) Reduction in exopolysaccharide viscosity as an aid to bacteriophage penetration through Pseudomonas aeruginosa biofilms. Appl Environ Microbiol 67:2746ā2753. https://doi.org/10.1128/AEM.67.6.2746-2753.2001
Sutherland IW (1999) Polysaccharases for microbial exopolysaccharides. Carbohydr Polym 38:319ā328. https://doi.org/10.1016/S0144-8617(98)00114-3
Linhardt RJ, Galliher PM, Cooney CL (1987) Polysaccharide lyases. Appl Biochem Biotechnol 12:135ā176. https://doi.org/10.1007/BF02798420
Leiman PG, Battisti AJ, Bowman VD et al (2007) The structures of bacteriophages K1E and K1-5 explain processive degradation of polysaccharide capsules and evolution of new host specificities. J Mol Biol 371:836ā849. https://doi.org/10.1016/j.jmb.2007.05.083
Nwodo UU, Green E, Okoh AI (2012) Bacterial exopolysaccharides: functionality and prospects. Int J Mol Sci 13:14002ā14015
Scholl D, Adhya S, Merril C (2005) Escherichia coli K1ās capsule is a barrier to bacteriophage T7. Appl Environ Microbiol 71:4872ā4874. https://doi.org/10.1128/AEM.71.8.4872-4874.2005
Cornelissen A, Ceyssens PJ, Krylov VN et al (2012) Identification of EPS-degrading activity within the tail spikes of the novel Pseudomonas putida phage AF. Virology 434:251ā256. https://doi.org/10.1016/j.virol.2012.09.030
Coulon C, Vinogradov E, Filloux A, Sadovskaya I (2010) Chemical analysis of cellular and extracellular carbohydrates of a biofilm-forming strain Pseudomonas aeruginosa PA14. PLoS One 5. https://doi.org/10.1371/journal.pone.0014220
Colvin KM, Irie Y, Tart CS et al (2012) The Pel and Psl polysaccharides provide Pseudomonas aeruginosa structural redundancy within the biofilm matrix. Environ Microbiol 14:1913ā1928. https://doi.org/10.1111/j.1462-2920.2011.02657.x
Wu JA, Kusuma C, Mond JJ, Kokai-Kun JF (2003) Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces. Antimicrob Agents Chemother 47:3407ā3414. https://doi.org/10.1128/AAC.47.11.3407-3414.2003
Aguinaga A, FrancĆ©s ML, Del Pozo JL et al (2011) Lysostaphin and clarithromycin: a promising combination for the eradication of Staphylococcus aureus biofilms. Int J Antimicrob Agents 37:585ā587. https://doi.org/10.1016/j.ijantimicag.2011.02.009
Drilling AJ, Cooksley C, Chan C et al (2016) Fighting sinus-derived Staphylococcus aureus biofilms in vitro with a bacteriophage-derived muralytic enzyme. Int Forum Allergy Rhinol 6:349ā355. https://doi.org/10.1002/alr.21680
Roach DR, Donovan DM (2015) Antimicrobial bacteriophage-derived proteins and therapeutic applications. Bacteriophage 5:e1062590. https://doi.org/10.1080/21597081.2015.1062590
Wan X, Hendrix H, Skurnik M, Lavigne R (2021) Phage-based target discovery and its exploitation towards novel antibacterial molecules. Curr Opin Biotechnol 68:1ā7. https://doi.org/10.1016/J.COPBIO.2020.08.015
Yan J, Mao J, Xie J (2014) Bacteriophage polysaccharide depolymerases and biomedical applications. BioDrugs 28:265ā274. https://doi.org/10.1007/S40259-013-0081-Y/METRICS
RodrĆguez-Rubio L, MartĆnez B, Donovan DM et al (2013) Bacteriophage virion-associated peptidoglycan hydrolases: potential new enzybiotics. Crit Rev Microbiol 39:427ā434. https://doi.org/10.3109/1040841X.2012.723675
Sharma U, Paul VD (2017) Bacteriophage lysins as antibacterials. Crit Care 21:99. https://doi.org/10.1186/s13054-017-1681-6
Borysowski J, Weber-Daį¹browska B, GĆ³rski A (2006) Bacteriophage endolysins as a novel class of antibacterial agents. Exp Biol Med 231:366ā377
Nelson D, Loomis L, Fischetti VA (2001) Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme. Proc Natl Acad Sci U S A 98:4107ā4112. https://doi.org/10.1073/pnas.061038398
Briers Y, Volckaert G, Cornelissen A et al (2007) Muralytic activity and modular structure of the endolysins of Pseudomonas aeruginosa bacteriophages? KZ and EL. Mol Microbiol 65:1334ā1344. https://doi.org/10.1111/j.1365-2958.2007.05870.x
Walmagh M, Briers Y, Santos SB dos et al (2012) Characterization of modular bacteriophage endolysins from myoviridae phages OBP, 201Ļ2-1 and PVP-SE1. PLoS One 7:e36991. https://doi.org/10.1371/journal.pone.0036991
Chanishvili N (2012) Phage therapy-history from Twort and dāHerelle through soviet experience to current approaches. Adv Virus Res 83:3ā40
MiÄdzybrodzki R, Hoyle N, Zhvaniya F et al (2021) Current updates from the long-standing phage research centers in Georgia, Poland, and Russia. Bacteriophages 921ā951. https://doi.org/10.1007/978-3-319-41986-2_31
Schmelcher M, Donovan DM, Loessner MJ (2012) Bacteriophage endolysins as novel antimicrobials. Future Microbiol 7:1147ā1171
Matsuda M, Barksdale L (1966) Phage-directed synthesis of diphtherial toxin in non-toxinogenic Corynebacterium diphtheriae. Nature 210:911ā913. https://doi.org/10.1038/210911a0
Fujii N, Oguma K, Yokosawa N et al (1988) Characterization of bacteriophage nucleic acids obtained from Clostridium botulinum types C and D. Appl Environ Microbiol 54:69ā73. https://doi.org/10.1128/aem.54.1.69-73.1988
OāBrien AD, Newland JW, Miller SF et al (1984) Shiga-like toxin-converting phages from Escherichia coli strains that cause hemorrhagic colitis or infantile diarrhea. Science (80- ) 226:694ā696. https://doi.org/10.1126/science.6387911
RodrĆguez-Rubio L, Haarmann N, Schwidder M et al (2021) Bacteriophages of shiga toxin-producing escherichia coli and their contribution to pathogenicity. Pathogens 10. https://doi.org/10.3390/pathogens10040404
Silpe JE, Wong JWH, Owen SV et al (2022) The bacterial toxin colibactin triggers prophage induction. Nature 6037900(603):315ā320. https://doi.org/10.1038/s41586-022-04444-3
Nedialkova LP, Sidstedt M, Koeppel MB et al (2016) Temperate phages promote colicin-dependent fitness of Salmonella enterica serovar Typhimurium. Environ Microbiol 18:1591ā1603. https://doi.org/10.1111/1462-2920.13077
Hilsenbeck JL, Park H, Chen G et al (2004) Crystal structure of the cytotoxic bacterial protein colicin B at 2.5 Ć resolution. Mol Microbiol 51:711ā720. https://doi.org/10.1111/j.1365-2958.2003.03884.x
Kronheim S, Daniel-Ivad M, Duan Z et al (2018) A chemical defence against phage infection. Nature 564:283ā286. https://doi.org/10.1038/s41586-018-0767-x
Nicholson J, Lindon J, Xenobiotica EH-, 1999 undefined (2008) āMetabonomicsā: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR. Taylor Fr 29:1181ā1189. https://doi.org/10.1080/004982599238047
Klassen A, Faccio AT, Canuto GAB et al (2017) Metabolomics: definitions and significance in systems biology. Adv Exp Med Biol 965:3ā17. https://doi.org/10.1007/978-3-319-47656-8_1/FIGURES/2
Roberts LD, Souza AL, Gerszten RE, Clish CB (2012) Targeted metabolomics. Curr Protoc Mol Biol 98:30.2.1ā30.2.24. https://doi.org/10.1002/0471142727.MB3002S98
Vinayavekhin N, Saghatelian A (2010) Untargeted metabolomics. Curr Protoc Mol Biol. https://doi.org/10.1002/0471142727.MB3001S90
Fiehn O (2002) Metabolomics ā the link between genotypes and phenotypes. Funct Genomics 155ā171. https://doi.org/10.1007/978-94-010-0448-0_11
Griffin JL (2006) The Cinderella story of metabolic profiling: does metabolomics get to go to the functional genomics ball? Philos Trans R Soc B Biol Sci 361:147ā161. https://doi.org/10.1098/RSTB.2005.1734
Fiehn O, Robertson D, Griffin J et al (2007) The metabolomics standards initiative (MSI). Metabolomics 3:175ā178. https://doi.org/10.1007/S11306-007-0070-6/FIGURES/2
Rosato A, Tenori L, Cascante M et al (2018) From correlation to causation: analysis of metabolomics data using systems biology approaches. Metabolomics 144(14):1ā20. https://doi.org/10.1007/S11306-018-1335-Y
Zhao X, Shen M, Jiang X et al (2017) Transcriptomic and metabolomics profiling of phage-host interactions between phage PaP1 and Pseudomonas aeruginosa. Front Microbiol 8:548. https://doi.org/10.3389/FMICB.2017.00548/BIBTEX
Zhao X, Chen C, Jiang X et al (2016) Transcriptomic and metabolomic analysis revealed multifaceted effects of phage protein Gp70.1 on Pseudomonas aeruginosa. Front Microbiol 7:1519. https://doi.org/10.3389/FMICB.2016.01519/BIBTEX
Chevallereau A, Blasdel BG, De Smet J et al (2016) Next-generation ā-omicsā approaches reveal a massive alteration of host RNA metabolism during bacteriophage infection of Pseudomonas aeruginosa. PLoS Genet 12:e1006134. https://doi.org/10.1371/JOURNAL.PGEN.1006134
Hsu BB, Gibson TE, Yeliseyev V et al (2019) Dynamic modulation of the gut microbiota and metabolome by bacteriophages in a mouse model. Cell Host Microbe 25:803ā814.e5. https://doi.org/10.1016/J.CHOM.2019.05.001
Han ML, Nang SC, Lin YW et al (2022) Comparative metabolomics revealed key pathways associated with the synergistic killing of multidrug-resistant Klebsiella pneumoniae by a bacteriophage-polymyxin combination. Comput Struct Biotechnol J 20:485ā495. https://doi.org/10.1016/J.CSBJ.2021.12.039
Sonkar K, Purusottam RN, Sinha N (2012) Metabonomic study of host-phage interaction by nuclear magnetic resonance- and statistical total correlation spectroscopy-based analysis. Anal Chem 84:4063ā4070. https://doi.org/10.1021/AC300096J/SUPPL_FILE/AC300096J_SI_001.PDF
Ankrah NYD, May AL, Middleton JL et al (2014) Phage infection of an environmentally relevant marine bacterium alters host metabolism and lysate composition. ISME J 85(8):1089ā1100. https://doi.org/10.1038/ismej.2013.216
Lorenzo-Rebenaque L, Casto-Rebollo C, Diretto G et al (2022) Examining the effects of Salmonella phage on the caecal microbiota and metabolome features in Salmonella-free broilers. Front Genet 13:3219. https://doi.org/10.3389/FGENE.2022.1060713/BIBTEX
Perez de Souza L, Alseekh S, Scossa F, Fernie AR (2021) Ultra-high-performance liquid chromatography high-resolution mass spectrometry variants for metabolomics research. Nat Methods 187(18):733ā746. https://doi.org/10.1038/s41592-021-01116-4
Saccenti E, Hoefsloot HCJ, Smilde AK et al (2014) Reflections on univariate and multivariate analysis of metabolomics data. Metabolomics 10:361ā374. https://doi.org/10.1007/S11306-013-0598-6/FIGURES/6
Kumar N, Hoque MA, Sugimoto M (2018) Robust volcano plot: identification of differential metabolites in the presence of outliers. BMC Bioinform 19:128. https://doi.org/10.1186/s12859-018-2117-2
Pinto RC (2017) Chemometrics methods and strategies in metabolomics. Adv Exp Med Biol 965:163ā190. https://doi.org/10.1007/978-3-319-47656-8_7/FIGURES/5
Considine EC, Thomas G, Boulesteix AL et al (2018) Critical review of reporting of the data analysis step in metabolomics. Metabolomics 14:1ā16. https://doi.org/10.1007/S11306-017-1299-3/TABLES/17
Cho HW, Kim SB, Jeong MK et al (2008) Discovery of metabolite features for the modelling and analysis of high-resolution NMR spectra. Int J Data Min Bioinform 2:176. https://doi.org/10.1504/IJDMB.2008.019097
Wang M, Carver JJ, Phelan VV et al (2016) Sharing and community curation of mass spectrometry data with global natural products social molecular networking. Nat Biotechnol 34:828ā837. https://doi.org/10.1038/NBT.3597
DĆ¼hrkop K, Fleischauer M, Ludwig M et al (2019) (2019) SIRIUS 4: a rapid tool for turning tandem mass spectra into metabolite structure information. Nat Methods 164(16):299ā302. https://doi.org/10.1038/s41592-019-0344-8
Horai H, Arita M, Kanaya S et al (2010) MassBank: a public repository for sharing mass spectral data for life sciences. J Mass Spectrom 45:703ā714. https://doi.org/10.1002/JMS.1777
Mehta SS (2020) MassBank of North America (MoNA): an open-access, auto-curating mass spectral database for compound identification in metabolomics presentation
Chenomx Inc | Metabolite discovery and measurement. https://www.chenomx.com/. Accessed 28 Apr 2023
Sumner LW, Amberg A, Barrett D et al (2007) Proposed minimum reporting standards for chemical analysis. Metabolomics 3:211ā221. https://doi.org/10.1007/s11306-007-0082-2
Howard-Varona C, Lindback MM, Bastien GE et al (2020) Phage-specific metabolic reprogramming of virocells. ISME J 144(14):881ā895. https://doi.org/10.1038/s41396-019-0580-z
Kanehisa M, Subramaniam (2002) The KEGG database. Novartis Found Symp 247:91ā103. https://doi.org/10.1002/0470857897.CH8
Kanehisa M, Furumichi M, Sato Y et al (2021) KEGG: integrating viruses and cellular organisms. Nucleic Acids Res 49:D545āD551. https://doi.org/10.1093/NAR/GKAA970
Keseler IM, Gama-Castro S, Mackie A et al (2021) The EcoCyc database in 2021. Front Microbiol 12:2098. https://doi.org/10.3389/FMICB.2021.711077/BIBTEX
Papaianni M, Cuomo P, Fulgione A et al (2020) Bacteriophages promote metabolic changes in bacteria biofilm. Microorganisms 8:480. https://doi.org/10.3390/MICROORGANISMS8040480
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
Ā© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Dantas, R., Brocchi, M., Pacheco Fill, T. (2023). Chemical-Biology and Metabolomics Studies in Phage-Host Interactions. In: Pacheco Fill, T. (eds) Microbial Natural Products Chemistry. Advances in Experimental Medicine and Biology(), vol 1439. Springer, Cham. https://doi.org/10.1007/978-3-031-41741-2_4
Download citation
DOI: https://doi.org/10.1007/978-3-031-41741-2_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-41740-5
Online ISBN: 978-3-031-41741-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)